Evotec Investor
Evotec is a pharmaceutical company providing drug discovery solutions to pharmaceutical and biotechnology companies.
Invests into
Technology:
AgeTech Companies, Biopharma, Biotechnology, Cell_Therapies, Pharmaceutical
Industry:
AI, CRO, End-to-end Drug Development
Headquarters:
Hamburg, Hamburg, Germany
Founded Date:
1993-01-01
Employees Number:
1001-5000
Funding Status:
IPO
Number Of Exits:
3
Acquisitions Number:
13
Investors Number:
10
Total Funding:
429645217
Estimated Revenue:
$100M to $500M
Last Funding Date:
2023-03-24
Last Funding Type:
Grant
Register and Claim Ownership